301 related articles for article (PubMed ID: 17965749)
1. Intermedin (adrenomedullin-2): a novel counter-regulatory peptide in the cardiovascular and renal systems.
Bell D; McDermott BJ
Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S247-62. PubMed ID: 17965749
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of intermedin on cardiovascular, pulmonary and renal diseases: comparison with adrenomedullin and CGRP.
Holmes D; Campbell M; Harbinson M; Bell D
Curr Protein Pept Sci; 2013 Jun; 14(4):294-329. PubMed ID: 23745696
[TBL] [Abstract][Full Text] [Related]
3. Intermedin/adrenomedullin-2 acts within central nervous system to elevate blood pressure and inhibit food and water intake.
Taylor MM; Bagley SL; Samson WK
Am J Physiol Regul Integr Comp Physiol; 2005 Apr; 288(4):R919-27. PubMed ID: 15576658
[TBL] [Abstract][Full Text] [Related]
4. Intermedin/adrenomedullin2: an autocrine/paracrine factor in vascular homeostasis and disease.
Ni X; Zhang J; Tang C; Qi Y
Sci China Life Sci; 2014 Aug; 57(8):781-9. PubMed ID: 25104450
[TBL] [Abstract][Full Text] [Related]
5. Adrenomedullin 2/intermedin in the hypothalamo-pituitary-adrenal axis.
Takahashi K; Morimoto R; Hirose T; Satoh F; Totsune K
J Mol Neurosci; 2011 Feb; 43(2):182-92. PubMed ID: 20596793
[TBL] [Abstract][Full Text] [Related]
6. Structure-function analyses reveal a triple β-turn receptor-bound conformation of adrenomedullin 2/intermedin and enable peptide antagonist design.
Roehrkasse AM; Booe JM; Lee SM; Warner ML; Pioszak AA
J Biol Chem; 2018 Oct; 293(41):15840-15854. PubMed ID: 30139742
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of components of the cardiomyocyte adrenomedullin/intermedin receptor system following blood pressure reduction in nitric oxide-deficient hypertension.
Zhao Y; Bell D; Smith LR; Zhao L; Devine AB; McHenry EM; Nicholls DP; McDermott BJ
J Pharmacol Exp Ther; 2006 Mar; 316(3):1269-81. PubMed ID: 16326922
[TBL] [Abstract][Full Text] [Related]
8. Endothelium-derived intermedin/adrenomedullin-2 protects human ventricular cardiomyocytes from ischaemia-reoxygenation injury predominantly via the AM₁ receptor.
Bell D; Campbell M; McAleer SF; Ferguson M; Donaghy L; Harbinson MT
Peptides; 2016 Feb; 76():1-13. PubMed ID: 26743504
[TBL] [Abstract][Full Text] [Related]
9. Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes.
Roh J; Chang CL; Bhalla A; Klein C; Hsu SY
J Biol Chem; 2004 Feb; 279(8):7264-74. PubMed ID: 14615490
[TBL] [Abstract][Full Text] [Related]
10. Immunocytochemical localization of adrenomedullin 2/intermedin-like immunoreactivity in human hypothalamus, heart and kidney.
Takahashi K; Kikuchi K; Maruyama Y; Urabe T; Nakajima K; Sasano H; Imai Y; Murakami O; Totsune K
Peptides; 2006 Jun; 27(6):1383-9. PubMed ID: 16359754
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms involved in the regional haemodynamic effects of intermedin (adrenomedullin 2) compared with adrenomedullin in conscious rats.
Jolly L; March JE; Kemp PA; Bennett T; Gardiner SM
Br J Pharmacol; 2009 Aug; 157(8):1502-13. PubMed ID: 19681873
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of calcitonin gene-related peptide (CGRP) related peptides (CGRP, amylin, adrenomedullin and adrenomedullin-2/intermedin) in goldfish (Carassius auratus): cloning and distribution.
Martínez-Alvarez RM; Volkoff H; Cueto JA; Delgado MJ
Peptides; 2008 Sep; 29(9):1534-43. PubMed ID: 18539360
[TBL] [Abstract][Full Text] [Related]
13. Intermedin enhances sympathetic outflow via receptor-mediated cAMP/PKA signaling pathway in nucleus tractus solitarii of rats.
Li P; Sun HJ; Han Y; Wang JJ; Zhang F; Tang CS; Zhou YB
Peptides; 2013 Sep; 47():1-6. PubMed ID: 23816795
[TBL] [Abstract][Full Text] [Related]
14. AM₁-receptor-dependent protection by intermedin of human vascular and cardiac non-vascular cells from ischaemia-reperfusion injury.
Bell D; Campbell M; Ferguson M; Sayers L; Donaghy L; O'Regan A; Jewhurst V; Harbinson M
J Physiol; 2012 Mar; 590(5):1181-97. PubMed ID: 22183724
[TBL] [Abstract][Full Text] [Related]
15. Adrenomedullin 2/intermedin is a slow off-rate, long-acting endogenous agonist of the adrenomedullin
Babin KM; Karim JA; Gordon PH; Lennon J; Dickson A; Pioszak AA
J Biol Chem; 2023 Jun; 299(6):104785. PubMed ID: 37146967
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of intermedin/adrenomedullin-2 in a cellular model of human pulmonary arterial hypertension.
Holmes D; Corr M; Thomas G; Harbinson M; Campbell M; Spiers P; Bell D
Peptides; 2020 Apr; 126():170267. PubMed ID: 32017948
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular effects of exogenous adrenomedullin and CGRP in Ramp and Calcrl deficient mice.
Pawlak JB; Wetzel-Strong SE; Dunn MK; Caron KM
Peptides; 2017 Feb; 88():1-7. PubMed ID: 27940069
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of intermedin (adrenomedullin-2) in healthy human volunteers and patients with heart failure.
Bell D; Gordon BJ; Lavery A; Megaw K; Kinney MO; Harbinson MT
Peptides; 2016 Feb; 76():19-29. PubMed ID: 26767798
[TBL] [Abstract][Full Text] [Related]
19. Intermedin 1-53 inhibits rat cardiac fibroblast activation induced by angiotensin II.
Yang JH; Cai Y; Duan XH; Ma CG; Wang X; Tang CS; Qi YF
Regul Pept; 2009 Nov; 158(1-3):19-25. PubMed ID: 19523990
[TBL] [Abstract][Full Text] [Related]
20. Calcitonin gene-related peptide-evoked sustained tachycardia in calcitonin receptor-like receptor transgenic mice is mediated by sympathetic activity.
Kunz TH; Scott M; Ittner LM; Fischer JA; Born W; Vogel J
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2155-60. PubMed ID: 17660394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
